Back | Next |
home / stock / fgen / fgen message board
Subject | By | Source | When |
---|---|---|---|
FibroGen Kidney-Disease Drug Set Back as FDA Panel | conix | investorshub | 07/18/2021 2:35:30 PM |
Chart | conix | investorshub | 04/10/2021 7:10:03 PM |
Is Fibrogen Still a Buy Following Data Analysis | conix | investorshub | 04/09/2021 3:22:30 PM |
Might reverse here | PStockPickz | investorshub | 04/08/2021 4:56:26 PM |
Yeah read that yesterday- not very concerning to | honest dave | investorshub | 04/08/2021 1:41:12 PM |
* * $FGEN Video Chart 04-07-2021 * * | ClayTrader | investorshub | 04/07/2021 10:12:15 PM |
Scam | PStockPickz | investorshub | 04/07/2021 8:39:01 PM |
https://www.biopharmadive.com/news/fibrogen-anemia-false-cardiovascular-safety-d | PStockPickz | investorshub | 04/07/2021 5:36:01 PM |
2 gaps and this pos can't even bounce . | PStockPickz | investorshub | 04/07/2021 5:34:34 PM |
LOL 35% dip cuz people got NO patience. | honest dave | investorshub | 04/07/2021 1:50:04 PM |
BTFWUHAND | viperdeal | investorshub | 03/11/2020 2:59:44 PM |
Rip commons | MikeBK205 | investorshub | 11/11/2019 9:32:19 PM |
https://seekingalpha.com/article/4096405-fibrogen-posts-positive-lung-fibrosis-r | Inoviorulez | investorshub | 08/08/2017 8:58:47 PM |
Milestone payments over 850 million alone ! | Oger | investorshub | 08/07/2017 9:16:24 PM |
Oh Lordy!!!! Here we go!! | Oger | investorshub | 08/07/2017 9:05:27 PM |
Accumulating FGEN at these levels. | Canoepaddler | investorshub | 01/13/2017 6:28:04 PM |
http://seekingalpha.com/article/3987002-fibrogen-look-long-term-biotech-winner?s | ronpopeil | investorshub | 07/09/2016 12:12:21 PM |
Movers and Shakers in Biotech: One Up, One | nyctraydr | investorshub | 02/12/2016 4:29:58 PM |
$FGEN recent news/filings | stocktrademan | investorshub | 12/02/2015 8:30:21 PM |
Phase 2 Data for Investigational Orally Active HIF-PHI | LongRun8 | investorshub | 10/23/2015 2:42:57 AM |
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, June 18, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host the second part of its virtual KOL investor event series on Wednesday, June 26, 2024 at 10:00 AM ET. To register, click here . The event will feature Rahul Aggarwal, M.D. (Uni...
2024-06-12 09:44:18 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 12, 2024 – USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovere...
FibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO ® in patients with select solid tumors FibroGen to evaluate FG-3175, an anti-c-c motif chemokine receptor 8 (CCR8) mAb, a...